By Taylor Mixides (Drug Target Review)2023-06-01T16:00:10
Scientists have discovered that a vaccinated San Diego resident has produced antibodies that are effective against multiple variants of SARS-CoV-2, including Omicron. The research also identified three antibodies that can neutralise the virus, giving new insights into different binding mechanisms with the SARS-CoV-2 spike protein. The findings could help to ...
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-03-31T14:05:00Z
2026-03-27T13:06:00Z
2024-02-01T12:06:43
Sponsored by Leica Microsystems
2025-10-08T14:00:00
Sponsored by Eurofins Discovery
2023-01-05T14:41:33
Sponsored by Cell Signaling Technology
2023-03-23T14:46:21
Sponsored by Bio-Techne
2023-01-19T15:38:17
Sponsored by Cell Signaling Technology
2023-11-24T12:06:45
Sponsored by Quantum-Si
Site powered by Webvision Cloud